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The emergence of antimicrobial-resistant and virulent enterococci is a major public health concern. While enterococci are
commonly found in food of animal origin, the knowledge on their zoonotic potential is limited. The aim of this study was to
determine and compare the antimicrobial susceptibility and virulence traits of Enterococcus faecalis and Enterococcus faecium
isolates from human clinical specimens and retail red meat in Slovenia. A total of 242 isolates were investigated: 101 from humans
(71 E. faecalis, 30 E. faecium) and 141 from fresh beef and pork (120 E. faecalis, 21 E. faecium). The susceptibility to 12 antimicrobials
was tested using a broth microdilution method, and the presence of seven common virulence genes was investigated using PCR. In
both species, the distribution of several resistance phenotypes and virulence genes was disparate for isolates of different origin. All
isolates were susceptible to daptomycin, linezolid, teicoplanin, and vancomycin. In both species, the susceptibility to antimicrobials
was strongly associatedwith a food origin and themultidrug resistance, observed in 29.6%ofE. faecalis and 73.3%E. faecium clinical
isolates, with a clinical origin (Fisher’s exact test). Among meat isolates, in total 66.0% of E. faecalis and E. faecium isolates were
susceptible to all antimicrobials tested and 32.6% were resistant to either one or two antimicrobials. In E. faecalis, several virulence
genes were significantly associated with a clinical origin; themost common (31.0%) gene pattern included all the tested genes except
hyl. In meat isolates, the virulence genes were detected in E. faecalis only and themost common pattern included ace, efaA, and gelE
(32.5%), of which gelE showed a statistically significant association with a clinical origin. These results emphasize the importance
of E. faecalis in red meat as a reservoir of virulence genes involved in its persistence and human infections with reported severe
outcomes.
1. Introduction
Enterococci are ubiquitous bacteria that primarily inhabit the
intestinal tract of humans and warm-blooded animals, where
they are part of the normal microbiota [1]. In addition, they
are found in many foods of animal and plant origin as they
are able to survive many adverse environmental conditions
and play an important beneficial role in the production of
various traditional fermented foods with unique organoleptic
properties [1–4]. They are also employed in the biopreser-
vation of foodstuffs as they produce several bactericidal
substances like lactic acid and bacteriocins (enterocins) [5,
6]. The latter exert antimicrobial activity against several
important Gram-positive foodborne pathogens including
Listeria monocytogenes, Staphylococcus aureus, and Clostrid-
ium botulinum [7–12]. Enterococci are also used as probiotics
for humans and animals, but their ability to acquire virulence
and antibiotic resistance genes through horizontal gene
transfer should be considered as a significant obstacle to
their use as probiotics or as starter/adjunct cultures in foods
[6, 8, 13].
Enterococci are among the leading nosocomial
pathogens; they can be transmitted person-to-person, and
also through contaminated food or environment, causing
soft tissue or wound infections, bacteraemia, endocarditis,
and especially infections of the urinary tract [3, 8, 14–16].
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Due to their ability to invade the extraintestinal regions by
translocation across an intact intestinal epithelium, they
can shift from commensals to pathogens [17]. Enterococcus
faecalis and Enterococcus faecium are the most common
enterococcal species detected in clinical and food samples.
In the first wave of nosocomial enterococcal infections,
E. faecalis was responsible for approximately 90% of the
human infections and E. faecium for the remaining 10%
[1, 18, 19]. However, over the past two decades, the second
wave has commenced with E. faecium, which is much more
frequently resistant to vancomycin (VRE), ampicillin (ARE),
and high levels of aminoglycosides (HLAR) than E. faecalis
[20, 21].
Enterococci are intrinsically resistant or tolerant to many
antimicrobials and easily acquire the high-level drug resis-
tance via horizontal gene transfer.The natural resistance of E.
faecalis and E. faecium includes cephalosporins, aminoglyco-
sides (low-level resistance), macrolides, and sulphonamides,
also clindamycin and quinupristin/dalfopristin in E. faecalis
[22]. Moreover, enterococci are showing the potential for
resistance to virtually all antimicrobials used in human
infections [23]. Some strains are multidrug-resistant (MDR),
i.e., resistant to three or more groups of antimicrobial agents
[1, 23, 24]. The resistance to vancomycin or teicoplanin is
of special concern due to the important therapeutic use
of these agents against the MDR enterococci and other
Gram-positive bacteria [23, 24]. Ampicillin, vancomycin,
and gentamicin are the most relevant antimicrobials for the
treatment of MDR enterococcal infections, but the extensive
use of vancomycin generated a raise in the number of VRE
that constitute a serious risk group [4, 25]. Enterococci
resistant to antimicrobials, including VRE, play an important
role in the inter- and intraspecies transfer of antimicrobial
resistance genes [26].
Since enterococci are present in the intestine of ani-
mals, contamination of meat during slaughter is common.
Enterococci should be screened for specific genetic traits
that determine their virulence potential, aiming also to
confirm their zoonotic transmission, which represents a
serious health concern [27, 28]. Many factors determine the
virulence of Enterococcus species, for example, the ability to
colonize the gastrointestinal tract or to adhere to a range of
extracellular matrix proteins or to the epithelial cells [29].
Several enterococcal virulence genes that may be involved in
the onset of a disease in humans or exacerbation of the disease
symptoms have been described [30]. Importantly, many of
these determinants are also found in the strains isolated
from foods [3, 31]. The aggregation substance (asa1), gelati-
nase (gelE), cytolysin (cylA), enterococcal surface protein
(esp), hyaluronidase (hyl), collagen-binding-protein (ace),
endocarditis antigen (efaA), and extracellular superoxide are
among the most important enterococcal virulence determi-
nants [4, 32–34].
The aim of the present study was to determine and
compare for the first time in Slovenia the antimicrobial
resistance and the presence of virulence genes in E. faecalis
and E. faecium isolates recovered from human patients in
2016–2018 and from fresh beef and pork in 2017.
2. Materials and Methods
2.1. Enterococci fromHuman Clinical Specimens. Enterococci
were isolated in the National Laboratory of Health, Envi-
ronment and Food, Slovenia. From January 2016 to June
2018, a total of 14 E. faecium and 16 E. faecalis isolates were
retrieved from blood cultures. FromMarch to June 2018, 16 E.
faecium isolates were obtained from other clinical specimens,
i.e., urine (n=11), tracheal aspirate (n=2), abdominal drainage
aspirate (n=1), central venous catheter (n=1), and wound
(n=1). In the same period, 55 E. faecalis isolates from urine
(n=38), vagina (n=8), wound (n=4), primary sterile sites
(n=3), ear (n=1), and ejaculate (n=1) were obtained. In
total, 101 isolates (71 E. faecalis and 30 E. faecium) were
retrieved from clinical samples collected from the patients
during 2016–2018 in Slovenia. All specimens were culti-
vated in different selective and nonselective media according
to the standard protocols [35]. The suspect colonies were
identified by the matrix-assisted laser desorption/ionization
time-of-flight (MALDI-TOF) mass spectrometry (Microflex
LT system; Bruker Daltonics, Germany) according to the
manufacturer’s instructions.
2.2. Enterococci from Red Meat. From January to December
2017, 141 E. faecalis and E. faecium isolates were retrieved
from unpacked and packed chilled fresh pork and beef of
Slovenian and foreign origin. A total of 70 isolates (60 E.
faecalis, 10 E. faecium) were collected from fresh pork and 71
isolates (60 E. faecalis, 11 E. faecium) from fresh beef samples.
Sampling was performed throughout the territory of Slovenia
as a part of the national monitoring within the framework
of the European baseline study on antimicrobial resistance.
Sampling took place in the retail establishments that directly
supply the final consumer (trade). Original packages of pre-
packed meat were randomly selected from the sales display.
In the butcher’s shops, the sampler randomly selected a piece
ofmeat in the total weight of at least 100 g. Fresh beef and pork
samples were collected throughout the year and transported
in the cooling boxes to the laboratory of the Veterinary
Faculty, Slovenia. Twenty-five grams of eachmeat sample was
supplemented with 225ml of buffered peptone water (Biolife,
Italy), homogenized in a stomacher, and incubated at 37∘C
for 16–20 h. Subsequently, the liquid enrichment culture was
spreadwith a 10-𝜇l loop onto the selective Slanetz Bartley agar
(Biolife, Italy) andChromIDVRE chromogenic selective agar
(bioMerieux, France) for the detection and differentiation
of E. faecium and E. faecalis showing acquired vancomycin
resistance. The agar plates were incubated at 37∘C for 24–48
h. Isolates with typical morphology were selected and pure
subcultures from single colonies on the blood agar plateswere
obtained. The suspect colonies were identified by MALDI-
TOF mass spectrometry (see above).
2.3. Antimicrobial Susceptibility Testing. Isolates were phe-
notypically tested for their susceptibility to 12 different
antimicrobials using a broth microdilution method to deter-
mine the minimum inhibitory concentration (MIC). A total
of 242 isolates were tested with a commercially available
96-well broth microdilution plate (EUVENC, Sensititre,
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Trek Diagnostic Systems; Thermo Scientific, USA) follow-
ing the manufacturer’s instructions and including the fol-
lowing antimicrobials: ampicillin (AMP), chlorampheni-
col (CHL), ciprofloxacin (CIP), daptomycin (DAP), ery-
thromycin (ERY), gentamicin (GEN), linezolid (LZD), quin-
upristin/dalfopristin (Synercid, SYN), teicoplanin (TEI),
tetracycline (TET), tigecycline (TGC), and vancomycin
(VAN). MICs were determined after 24 h of incubation at
35∘C in aerobic conditions using the Sensititre cation adjusted
Mueller-Hinton broth with TES (CAMHBT, Sensititre, Trek
Diagnostic Systems; Thermo Scientific, USA) according to
the manufacturer’s instructions. The MIC endpoint was
determined as the next dilution above the last dilution where
growthwas observed. Reference strainE. faecalisATCC29212
was used as a control.
E. faecalis and E. faecium isolates were classified as
susceptible or resistant based on the epidemiological cut-
off values (ECOFFs) according to the European Committee
on Antibiotic Susceptibility Testing (EUCAST) [36] and
the recommendations of the EU Reference Laboratory for
Antimicrobial Resistance (EURL-AR) [37]. The evaluation
was based on the interpretation of MIC values obtained in
concordance with the Decision 2013/652/EU of the Euro-
pean Commission. Because E. faecalis exhibited the intrinsic
resistance to quinupristin/dalfopristin, MIC data for SYN
were not included in Table S1 and Table S2. The intrinsic
resistances were adopted from the EUCAST expert rules
[38] and were excluded from the result tables except for
gentamicin, to which enterococci exert only a low level of
intrinsic resistance. MIC50 and MIC90 were also determined,
both for human and meat isolates, describing MICs of the
tested antimicrobials required to inhibit the growth of 50%
and 90% of the obtained E. faecalis or E. faecium isolates,
respectively (Table S1 and Table S2).
2.4. Molecular Detection of Virulence Factors. Genes encod-
ing the enterococcal virulence factors ace, asa1, cylA, efaA,
esp, gelE, and hyl were detected using PCR. DNA was
extracted from the bacterial cultures grown on the sheep
blood agar plates with a simple cell lysis (boiling at 95∘C for 15
min, centrifugation at 14,000×g for 2 min). The supernatant
was used as a template for PCR without further purification.
Virulence genes were detected using twomultiplex PCR tests:
PCR 1 for the detection of asa1, cylA, esp, gelE, and hyl [32]
and PCR 2 for the detection of ace and efaA [39]. Briefly, a
25-𝜇l reaction mixture for both PCR assays contained 12.5 𝜇l
of 2× Multiplex PCR Master Mix (Qiagen, Germany), 2.5 𝜇l
of 10× primer mix (containing 2 𝜇M of each primer for asa1,
gelE, and hyl; 1 𝜇M of each primer for cylA and esp for PCR
1; and 2 𝜇M of each primer for ace and efaA for PCR 2), and
2.5 𝜇l of DNA template. An initial activation step at 95∘C for
15 min was followed by 30 cycles of denaturation at 94∘C for
30 sec, annealing for 90 sec (PCR 1: 56∘C, PCR 2: 55∘C), and
extension at 72∘C (PCR 1: 60 sec, PCR 2: 90 sec), followed
by one cycle at 72∘C for 10 min. Amplicons were detected
using the QIAxcel capillary electrophoresis system (Qiagen,
Germany).
2.5. Statistical Analysis. The Fisher’s exact test implemented
in the GraphPad Prism v6.01 (GraphPad Software, USA)
was used to assess the association between different traits
(origin of isolation, virulence gene, resistance phenotype).
To compare the isolates according to the origin of isolation,
isolates from beef and pork samples were joined into a
single group and compared to human isolates. To assess the
association between the antimicrobial resistance phenotypes
and virulence genes, isolates of different origin were joined
into a single group and compared according to the resistance
pattern. Each species was analyzed independently and only
groups with an expected frequency of >5 were compared.
For the analysis of correlation between the antimicrobial
resistance and virulence, the number of cooccurring resistant
phenotypes and virulence genes was considered. The p value
of ≤0.05 was considered as statistically significant.
3. Results and Discussion
Several studies demonstrated E. faecalis and/or E. faecium to
be the most common enterococcal species found in food of
animal origin [40–44].This is in accordance with the present
study, as E. faecalis and E. faecium were the predominant
species isolated from red meat, found in 69.5% and 11.3% of
the samples, respectively. In addition, Enterococcus species
E. hirae, E. casseliflavus, E. durans, E. devriesei, E. gilvus,
E. mundtii, and E. thailandicus were also isolated from
beef and pork samples (data not shown). E. faecium and
E. faecalis were also the predominant enterococcal species
isolated from healthy cattle, pigs, and chicken in nine EU
countries, detected in 30.6% and 25.7% of the investigated
samples, respectively [45]. The presence of enterococci in
food is considered as an indicator of faecal or environmental
contamination and represents a potential risk to human
health [26]. Enterococcal endocarditis remains one of the
most difficult enterococcal infections to treat due to the
high level of antimicrobial resistance observed [35, 46].
Enterococcal bacteraemia, associated with high mortality
rates [35, 46], represented 5.4–8.1% of human bloodstream
infections in 2006–2011 in Slovenia [47].
3.1. Antimicrobial Resistance. The antimicrobial susceptibil-
ity of E. faecalis and E. faecium isolates from humans and
red meat differed significantly for both species, as shown in
Table 1, Table S1, andTable S2. In both species, susceptible iso-
lates were strongly associated with a food origin (p<0.0001);
65.9% ofmeat isolates were classified as susceptible compared
to only 11.9% of human clinical isolates. All E. faecalis and
E. faecium isolates from both origins were susceptible to
daptomycin, linezolid, teicoplanin, and vancomycin. The
MDR phenotype was significantly overrepresented among
the human clinical isolates in comparison with the meat iso-
lates for both species (p<0.0001; Table 1). Among the clinical
isolates, mostly from blood cultures, 30.5% showed the MDR
phenotype. Almost one-third (29.6%) of E. faecalis isolates
from different clinical samples (blood cultures, urine, wound,
vagina, and ejaculate) were classified as MDR and the most
common resistance patternwas ERY-GEN-TET. In E. faecalis,
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Table 1: Overview of the susceptibility testing results for 191 Enterococcus faecalis and 51 Enterococcus faecium isolates from human clinical





No. of isolates [%]
Red meat









6 1 [1.4] 3 [10.0] 0 [0.0] 0 [0.0]
5 4 [5.6] ∗∗∗13 [43.3] 0 [0.0] 0 [0.0]
4 4 [5.6] 3 [10.0] 0 [0.0] 0 [0.0]
3 ∗∗12 [16.9] 3 [10.0] 2 [1.7] 0 [0.0]
MDR ∗∗∗∗21[29.6] ∗∗∗∗22 [73.3] 2 [1.7] 0 [0.0]
2 ∗∗∗14 [19.7] 3 [10.0] 4 [3.3] 1 [4.8]
1 27 [38.0] 2 [6.7] 39 [32.5] 2 [9.5]
Susceptible 9 [12.7] 3 [10.0] ∗∗∗∗75 [62.5] ∗∗∗∗18 [85.7]
Total 101 141
Note: significant associations (the Fisher’s exact test) of antimicrobial resistance/susceptibility and origin of isolation for each species are indicatedwith asterisks.
Significance levels: ∗∗𝑝 <0.005; ∗∗∗𝑝 <0.0005, ∗∗∗∗𝑝 <0.0001.
MDR denotes the multidrug resistance.
a significant association with a clinical origin was identified
for the following antibiotics: CIP (p<0.0001), ERY (p<0.0001),
GEN (p<0.0001), and TET (p<0.0001) (Figure 1(a)). Fur-
thermore, 73.3% of clinical E. faecium isolates from blood
cultures, urine, and tracheal aspirate were MDR with the
most common resistance pattern AMP-CIP-ERY-GEN-TGC.
In E. faecium, a significant association with a clinical origin
was identified for the following antibiotics: AMP (p=0.0002),
CIP (p<0.0001), ERY (p<0.0001), GEN (p<0.0001), SYN
(p=0.0001), and TGC (p<0.0001) (Figure 1(b)). Among the
meat isolates, only two (1.7%) E. faecalis isolates showed the
MDR resistance pattern (ERY-GEN-TET). Distributions of
MICs, MIC50, and MIC90 for the human clinical and meat
isolates are shown in Table S1 and Table S2.
In 2017, the Slovenian National Antimicrobial Suscepti-
bility Testing Committee reported a low resistance of human
clinical E. faecalis isolates to ampicillin (0.6%), linezolid
(0.4%), vancomycin (0.04%), and ciprofloxacin (0.5%) [48].
A higher resistance of E. faecalis was observed for nitrofu-
rantoin (24.2%) and high level of gentamicin (19.2%) [48].
E. faecalis has acquired resistance to gentamicin, but the
resistance to ampicillin and vancomycin is less common than
in E. faecium [49]. In the present study, only 12.7% of clinical
E. faecalis isolates from different clinical specimens were
susceptible to all antimicrobials tested (Table 1).Themajority
of clinical E. faecalis isolates were resistant to tetracycline
(78.9%), followed by the resistance to erythromycin (46.5%)
(Table S1, Figure 1(a)). Twenty (28.2%) clinical E. faecalis
isolates, originating from blood cultures, urine, vagina, oper-
ation wound, and ejaculate, showed the HLAR phenotype
(Table S1); of these, 15 isolates also showed the resistance
to tetracycline and erythromycin. In addition, two HLAR
isolates from blood cultures were also resistant to ampicillin
(MIC>64 𝜇g/ml) and ciprofloxacin (MIC>16 𝜇g/ml). A lower
frequency of resistance in clinical E. faecalis isolates was
noticed for ciprofloxacin (18.3%), tigecycline (7.0%), chlo-
ramphenicol (5.6%), and ampicillin (2.8%) (Table S1). These
findings contrast a study which reported higher resistance
rates of E. faecalis to tetracycline (88.0%), erythromycin
(62.3%), and ciprofloxacin (39.4%) [50].
As for human clinical E. faecium isolates, low resistance
was observed in Slovenia in 2017 for vancomycin (0.6%)
and linezolid (0.5%), while higher resistance rates were
reported for ampicillin (89.9%), ciprofloxacin (94.3%), and
high level of gentamicin (49.1%) [48]. In the present study,
most of the clinical E. faecium isolates were resistant to
erythromycin (76.7%), ampicillin (70.0%), and ciprofloxacin
(70.0%) (Table S1, Figure 1(b)). More than half (56.7%)
of the isolates, originating from blood cultures, urine, and
tracheal aspirate, were highly resistant to gentamicin (HLAR
E. faecium) (Table S1); among these, 15 were resistant also
to ampicillin, ciprofloxacin, and erythromycin. Resistance to
quinupristin/dalfopristin was observed in 56.7% of clinical
E. faecium isolates. Previous studies reported a wide range
(1–70%) of quinupristin/dalfopristin resistance in human
isolates [50, 51]. Furthermore, 30.0% of isolates were also
resistant to tigecycline, while the proportion of tetracycline-
resistant isolates was lower (13.3%). A higher rate of ampi-
cillin resistance in E. faecium compared to E. faecalis isolates
from human clinical samples is in congruence with previous
studies reporting that E. faecium isolates acquire ampicillin
and vancomycin resistance more frequently than E. faecalis,
which is less efficient in accumulating resistance, although
E. faecalis is responsible for more human infections than
E. faecium [25, 52]. On the other hand, E. faecium is an
important nosocomial pathogen and has acquired resistance
to different classes of antimicrobials. Moreover, MDR E.
faecium is associated with an increased mortality rate in
humans [49, 53].
Based on the ECOFFs, all red meat isolates were sus-
ceptible to ampicillin, chloramphenicol, daptomycin, line-
zolid, teicoplanin, and vancomycin (Table S2 and Figure 1).
Susceptibility to the last four antimicrobials is of particular
importance since they are categorized as critically important































































Figure 1: Antimicrobial resistance in Enterococcus isolates from human clinical specimens and red meat. (a) Enterococcus faecalis isolates
(𝑛 = 191). (b) Enterococcus faecium isolates (𝑛 = 51). Numbers at the top of each column indicate the number of isolates; only numbers ≥1
are shown. Significant associations (the Fisher’s exact test) of antimicrobial resistance and origin of isolation for each species are indicated
with asterisks. Significance levels: ∗𝑝 <0.05; ∗∗∗𝑝 <0.0005; ∗∗∗∗𝑝 <0.0001.
antimicrobials (CIA) in human medicine. In the present
study, VRE were not isolated from fresh pork and beef
samples.This is in agreement with some studies reporting the
absence of teicoplanin and vancomycin resistance in entero-
cocci from red meat [41–43, 54], but in contrast with other
studies describing the presence of VRE in raw meat [55, 56].
Almost one-third (32.6%) of red meat isolates were resistant
to either one or two antimicrobials; two E. faecalis meat
isolates were resistant to three (Table 1). In comparison, 63.0%
of isolates resistant to at least one antimicrobial tested were
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reported in Turkey [44] and only 3.4% of enterococci from
retail meat in Canada were susceptible to all antimicrobials
tested [42]. In the present study, E. faecalis meat isolates
were most often resistant to tetracycline (29.2%) (Table S2,
Figure 1(a)). Reduced susceptibility among E. faecalis isolates
was observed for tigecycline (9.2%) and ciprofloxacin (0.8%).
Two isolates (1.7%), one from pork and one from beef, were
classified as HLAR with MIC value for gentamicin >1024
𝜇g/ml. E. faeciummeat isolates showed a very low frequency
of antimicrobial resistance to ciprofloxacin, erythromycin,
quinupristin/dalfopristin, and tetracycline (4.8% each) (Table
S2, Figure 1(a)). Results of the present study were in congru-
ence with previous studies on the resistance of enterococci in
meat, with the exception of higher resistance to tetracyclines
in previous reports [41, 42, 54].
In 2013, Slovenia and three other EU countries reported
the antimicrobial resistance of enterococcal isolates from
broiler, pig, and bovine meat [57]. Overall, E. faecalis isolates
showed resistance to tetracyclines (42.2%), streptomycin
(11.1%), and erythromycin (6.7%). E. faecium isolates were
resistant to quinupristin/dalfopristin (50.0%) and tetracy-
clines (9.1%). In general, enterococci from pork and beef
were less resistant in comparison with enterococci from
broilermeat, except for chloramphenicol and linezolid. Slove-
nia reported resistance to the selected antimicrobials for
93 Enterococcus isolates from broiler meat and for 52 E.
faecalis isolates from pork. Among the latter, 50.0% were
resistant to tetracyclines, 21.2% to erythromycin, and 17.3% to
streptomycin [57]. Interestingly, a higher rate of antimicrobial
resistance in pork isolates was observed in 2013 than in
the present study. According to the current EU legislation,
the monitoring of antimicrobial resistance of enterococci (E.
faecalis and E. faecium) from animals and derived meat is
not mandatory. However, the surveillance of antimicrobial
resistance in enterococci from meat, in particular if it is
eaten raw and does not undergo the processing steps to
eliminate live bacteria before consumption, is important for
the assessment of possible zoonotic risks [58]. In the present
study, the reduced susceptibility was also observed for some
E. hirae and E. durans isolates from red meat with MIC
value of 128 𝜇g/ml for tetracycline (data not shown), which
may indicate a possible interspecies transfer of resistance
determinants. Enterococci are considered as reservoirs of
antimicrobial resistance genes, which can be transferred to
humans via the food chain. Identification of resistance genes,
in addition to the phenotypic characterization of resistance,
may provide additional information for the studied iso-
lates. However, according to the whole-genome sequencing
(WGS), E. faecalis and E. faecium resistance genotypes cor-
related with the resistance phenotypes in 96.5% of cases for
the 11 investigated antimicrobials [59]. This suggests that the
phenotypic susceptibility testing cannot yet be fully replaced
by WGS.
3.2. Virulence Genes. The results on the presence of virulence
genes are summarized in Tables 2 and 3. As expected and in
congruence with previous studies [31, 60–62], the virulence
traits were more commonly detected in clinical than in meat
isolates. A significant association between the presence of a
virulence gene and a clinical origin was identified among
E. faecalis isolates for asa1 (p<0.0001), cylA (p<0.0001), esp
(p<0.0001), and gelE (p=0.0005) genes (Table 2). This is in
congruence with previous studies, reporting the enterococcal
surface protein (esp) as one of the most important factors
for colonization and persistence of E. faecalis in human
urinary tract infections [63] and biofilm production [64].The
production of gelatinase (gelE) was also confirmed previously
in clinical E. faecalis strains, but its connection with biofilm
formation remains unclear [64]. A higher frequency of
adhesion genes (esp and asa1) and gelatinase (gelE) was
described for clinical E. faecalis isolates in comparison with
E. faecium [65].
In the present study, none of the isolates harbored all of
the virulence genes simultaneously. All the tested virulence
genes were found in human clinical isolates, whereas in
the red meat isolates all but hyl were detected (Table 2). A
simultaneous presence of more than two virulence genes was
demonstrated in 94.4% of E. faecalis and 13.3% of E. faecium
isolates from humans and in 68.3% of E. faecalis isolates
from red meat (Table 3). In the clinical E. faecalis isolates, 14
virulence gene patterns were discovered, with ace-asa1-cylA-
efaA-esp-gelE being the most common as it was detected in
one-third (n=22) of the isolates (Table 3), mostly from the
urine samples (n=13) but also from the blood culture (n=3),
vagina (n=3), wound (n=2), and ejaculate (n=1). Moreover,
73.2% (n=52) of clinical E. faecalis isolates harbored four or
more virulence genes at the same time, compared to only
10.0% (n=2) of clinical E. faecium isolates. These findings
contrast with a study which reported that isolates linked with
bacteraemia did not show any particular propensity for the
carriage of virulence genes, whereas isolates from the urinary
tract infections usually possessed two to four virulence traits
[66]. Among the six distinct virulence gene patterns found
in clinical E. faecium isolates, esp-hyl was the most frequent
as it was detected in half (n=16) of the isolates (Table 3),
mostly from the blood cultures (n=10) but also from the urine
samples (n=4) and tracheal aspirates (n=2).Moreover, far less
clinical E. faecium isolates harbored virulence genes than E.
faecalis, with the exception of esp (Table 3). The hyl gene was
found in 53.3% of E. faecium and in only 2.8% of E. faecalis
clinical isolates (Table 2). This gene is widely distributed
among the clinical E. faecium isolates and it was previously
considered as restricted to this species [67]. However, it has
been recently described also in E. faecalis [28, 65, 68], which
supports the findings of the present study. In addition, herein
we showed that esp and hyl were overrepresented among E.
faecium isolates of a clinical origin in comparison with food
isolates (p<0.0001) (Table 2). The incidence of esp in clinical
E. faecium is reported to be increasing compared to clinical
E. faecalis isolates [50]. The carriage of esp, coding for the
enterococcal surface protein, in enterococci from foods and
humans has also been described before [31, 69]. However,
it was more frequently observed in clinical isolates than in
commensal isolates [70] and it was found in a low proportion
in the meat samples [71, 72]. In the present study, esp was
detected in equally high proportions of clinical E. faecalis and
E. faecium, while its occurrence in the red meat E. faecalis
isolates was much lower.
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Table 2: The presence of virulence genes in 191 Enterococcus faecalis and 51 Enterococcus faecium isolates originating from human clinical




No. of isolates [%]
Red meat
No. of isolates [%]
E. faecalis E. faecium E. faecalis E. faecium
ace 54 [76.1] 4 [13.3] 92 [76.7] 0 [0.0]
asa1 ∗∗∗∗46 [64.8] 2 [6.7] 38 [31.7] 0 [0.0]
cylA ∗∗∗∗32 [45.1] 2 [6.7] 6 [5.0] 0 [0.0]
efaA 69 [97.2] 4 [13.3] 115 [95.8] 0 [0.0]
esp ∗∗∗∗51 [71.8] ∗∗∗∗21[70.0] 13 [10.8] 0 [0.0]
gelE ∗∗∗63 [88.7] 2 [6.7] 79 [65.8] 0 [0.0]
hyl 2 [2.8] ∗∗∗∗16 [53.3] 0 [0.0] 0 [0.0]
Total 71 30 120 21
ace: collagen-binding protein; asa1: aggregation substance; cylA: cytolysin; efaA: endocarditis antigen; esp: enterococcal surface protein; gelE: gelatinase; hyl:
hyaluronidase.
Note: significant associations (the Fisher’s exact test) of the presence of virulence gene and origin of isolation for each species are indicated with asterisks.
Significance levels: ∗∗∗𝑝 <0.0005; ∗∗∗∗𝑝 <0.0001.









E. faecalis E. faecium E. faecalis E. faecium
ace-asa1-cylA-efaA-esp-gelE 22 1 0 0
ace-asa1-cylA-efaA-gelE 2 0 1 0
ace-asa1-efaA-esp-gelE 2 0 0 0
ace-efaA-asa1-esp-cylA 4 0 4 0
asa1-cylA-efaA-esp-gelE 4 0 1 0
ace-asa1-cylA-efaA 0 1 0 0
ace-asa1-efaA-gelE 9 0 17 0
ace-efaA-esp-gelE 7 1 3 0
asa1-efaA-esp-gelE 2 0 1 0
ace-asa1-efaA 0 0 9 0
ace-efaA-esp 1 1 0 0
ace-efaA-gelE 7 0 39 0
asa1-efaA-esp 1 0 0 0
asa1-efaA-gelE 0 0 3 0
efaA-esp-gelE 6 0 4 0
ace-efaA 0 0 19 0
asa1-efaA 0 0 1 0
asa1-gelE 0 0 1 0
efaA-gelE 2 0 8 0
esp-hyl 2 16 0 0
efaA 0 0 5 0
esp 0 2 0 0
gelE 0 0 1 0
None 0 8 3 21
Total 71 30 120 21
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Genes coding for the virulence were not detected in
26.6% of clinical E. faecium isolates nor in any of E. faecium
isolated from meat (Table 3). However, according to the
literature, the presence of asa1, cylA, efaA, esp, gelE, and
hyl genes has been confirmed in E. faecium isolates from
meat and meat products [71, 73]. In general, E. faecalis
isolated from food is showing more virulence traits than
E. faecium [71]. E. faecium of animal origin is not highly
important for human infections, but should be considered
in the view of transferring the resistance genes to other
pathogenic enterococci [74]. Furthermore, also E. hirae and
E. mundtii could represent a reservoir of virulence genes, as
in the present study ace, asa1, and efaAwere found in E. hirae
and ace, efaA, and gelE in E. mundtii (data not shown). On
the other hand, E. faecalis of animal origin was reported as
a human hazard per se as the same types of E. faecalis were
found in animals, meat, human faecal samples, and patients
with enterococcal bacteraemia [74].
Results of the present study showed a high prevalence of
virulence genes in E. faecalis isolates from meat (Table 2).
More than three virulence genes were detected in 68.3%
of isolates (Table 3), which is a much higher percentage
than previously reported [62]. Furthermore, 97.5% of isolates
harbored at least one virulence gene (Table 3).This is in accor-
dance with a previous study, in which a higher percentage
of E. faecalis isolated from four meat types, including beef
and pork, was reported [42]. In the present study, the ace-
efaA-gelE virulence gene pattern was the most common for
E. faecalis from meat. This is an important finding as efaA
and gelEwere shown to be associatedwith the exacerbation of
infective endocarditis in humans [75, 76]. In addition, it has
been shown before that the presence of ace is often confirmed
in clinical and retail meat E. faecalis isolates [42, 66, 71]. This
is in accordance with the results of the present study, showing
that three-quarters of E. faecalis isolates from both origins
harbored acewhile it was found in only few clinicalE. faecium
isolates (Table 2).
Similarly, the concurrent expression of virulence factors
cytolysin and aggregation substance was reported to result
in the increased pathogenicity of E. faecalis isolates [77];
herein, the presence of both cylA and asa1 genes was con-
firmed in a small number of E. faecalis isolates from red
meat. Regardless of the gene patterns, the presence of asa1
was demonstrated in one-third of E. faecalis meat isolates
(Table 2), but its frequency in E. faecalis food isolates was
previously reported to be high [31, 42, 60, 71]. In the present
study, cylA was confirmed in low numbers of E. faecalis
meat isolates and E. faecium clinical isolates, while it was
more abundant in clinical E. faecalis (Table 2). Previously,
this gene was also reported in low numbers of isolates
originating from fermented dry sausages, beef, and pork
[42, 71].
Gene encoding the endocarditis antigen was the most
frequently detected virulence gene in both clinical and meat
E. faecalis isolates in the present study (Table 2), which is in
congruence with a study hypothesizing that efaA is important
also for the persistence of enterococci in environments other
than human tissues [78]. On the other hand, efaA was only
found in few clinical and none of the meat E. faecium isolates
(Table 2), which contrasts with the study reporting 63% efaA-
positive E. faecium isolates from food of animal origin [69].
Similarly, the presence of gelatinase encoding gene (gelE) was
also frequently demonstrated in E. faecalis clinical and meat
isolates, while it was rarely seen in clinical E. faecium isolates
(Table 2). This corresponds with previous reports on high
proportions of E. faecalis and low proportions of E. faecium
isolates from meat harboring gelE [42, 71, 72].
3.3. Association between Antimicrobial Resistance and Vir-
ulence Genes. In E. faecalis, a moderate positive correla-
tion between the phenotypic resistance and virulence genes
was observed (Spearman correlation coefficient rS=51.4%,
p<0.0001). Similarly, in E. faecium, a strong positive cor-
relation was observed (rS=71.9%, p<0.0001). Several sig-
nificant associations between the antimicrobial resistance
phenotype and virulence genes were identified (Table S3
and Table S4). In E. faecalis, the presence of asa1, esp, and
cylA genes was significantly associated with the resistance
to ERY, GEN, and TET (Table S3). In E. faecium, the
presence of esp and hyl genes was significantly associated
with the phenotypic resistance to AMP, CIP, ERY, GEN,
and TGC (Table S4). In both species, a positive association
between the presence of virulence genes and phenotypic
resistance wasmore evident in clinical isolates in comparison
with meat isolates. This suggests there is a cooccurrence
of resistance and virulence determinants in clinical isolates
belonging to both analyzed species, possibly due to the
antimicrobial treatment favoring the coselection of both
traits.
4. Conclusions
Herein, we revealed a relatively favorable situation regarding
the resistance of E. faecalis and E. faecium isolates from
human clinical specimens and red meat as all isolates
were susceptible to daptomycin, linezolid, teicoplanin, and
vancomycin, which is of particular importance since these
agents are categorized as CIA for human infections. In
addition, a considerably higher proportion of susceptible
isolates from meat compared to clinical isolates was shown.
Only 1.7% of meat isolates were MDR compared to 42.6%
of clinical isolates. Therefore, E. faecalis and E. faecium from
red meat most likely do not represent an important source
of resistant strains for human colonization of infection.
Clinical E. faecalis isolates showed an increased presence of
virulence genes as 47.9% of isolates harbored more than five
virulence genes simultaneously compared to 5% of meat E.
faecalis isolates. However, the most common combinations
of virulence genes in E. faecalis isolates from beef and
pork, including efaA, ace, and gelE, revealed a similarity
in virulence characteristics to human isolates. Even though
the most frequent virulence gene patterns in the red meat
isolates were less common in human isolates, beef and
pork could be regarded as a source of virulent E. faecalis
strains. In contrast, the red meat could not be assumed
as an important vehicle for the transmission of virulent E.
faecium.
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[4] M. R. Foulquié Moreno, P. Sarantinopoulos, E. Tsakalidou, and
L. De Vuyst, “The role and application of enterococci in food
and health,” International Journal of FoodMicrobiology, vol. 106,
no. 1, pp. 1–24, 2006.
[5] J. A. Reis, A. T. Paula, S. N. Casarotti, and A. L. B. Penna,
“Lactic acid bacteria antimicrobial compounds: characteristics
and applications,” Food Engineering Reviews, vol. 4, no. 2, pp.
124–140, 2012.
[6] I. Jaouani, M. S. Abbassi, S. C. Ribeiro et al., “Safety and tech-
nological properties of bacteriocinogenic enterococci isolates
from Tunisia,” Journal of Applied Microbiology, vol. 119, no. 4,
pp. 1089–1100, 2015.
[7] L. M. Cintas, P. Casaus, L. S. Håvarstein, P. E. Hernández, and I.
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